FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\cacSL.UAS.EGFP
Open Close
General Information
Symbol
Dmel\cacSL.UAS.EGFP
Species
D. melanogaster
Name
FlyBase ID
FBal0344040
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Transgenic product class
Nature of the Allele
Transgenic product class
Progenitor genotype
Carried in construct
Cytology
Description

UASt regulatory sequences drive expression of cac bearing a a serine 161 to leucine substitution corresponding to S218L in the human CACNA1A gene (a mutation associated with familial hemiplegic migraine). The protein is tagged with EGFP.

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

TC11977024CT

Amino acid change:

S161L | cac-PA; S161L | cac-PB; S161L | cac-PC; S161L | cac-PD; S161L | cac-PE; S161L | cac-PF; S161L | cac-PG; S161L | cac-PH; S161L | cac-PI; S161L | cac-PJ; S161L | cac-PL; S161L | cac-PM; S267L | cac-PN; S161L | cac-PO; S161L | cac-PP; S161L | cac-PS; S161L | cac-PT; S161L | cac-PU

Reported amino acid change:

S161L

Comment:

Analogous S218L mutation in human CACNA1A implicated in migraine, familial hemiplegic 1; mutation carried on in vitro construct; site of nucleotide substitution in fly gene inferred by FlyBase curator based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 1 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
This allele represents a human variant implicated in disease.
CACNA1A:p.Ser218Leu
Variants Synonym(s)
Associated human disease model(s)
External database links
Comments concerning this variant
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Early third instar larvae expressing cacSL.UAS.EGFP under the control of Scer\GAL4elav-C155 develop protruding anterior spiracles prematurely, which normally only develop at wandering third instar stage and pupation. Their decreased adult viability is more severe in males than in females. In CNS-removed larvae, NMJ neurotransmission shows a significant increase in mEPSP frequency, but not amplitude or rise time, and a significant increase in EPSP amplitude, but not quantal content, as compared to controls; larger spontaneous events are slower and there is rare gigantic spontaneous events, which are never observed in controls. Upon 30 presynaptic pulses, EPSP profiles exhibit shoulders and extra discharges.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference
Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (1)
Reported As
Symbol Synonym
cacSL.UAS.EGFP
Name Synonyms
Secondary FlyBase IDs
    References (3)